Literature DB >> 24001292

New designer drugs (synthetic cannabinoids and synthetic cathinones): review of literature.

Olivier Cottencin, Benjamin Rolland, Laurent Karila1.   

Abstract

New designer drugs (synthetic cannabinoids and synthetic cathinones) are new "legal highs" that are sold online for recreational public or private use. Synthetic cannabinoids are psychoactive herbal and chemical products that mimic the effects of cannabis when used. These drugs are available on the Internet or in head shops as incense or air fresheners to circumvent the law. Cathinone is a naturally occurring beta-ketone amphetamine analog found in the leaves of the Catha edulis plant. Synthetic cathinones are phenylalkylamine derivatives that may possess amphetamine-like properties. These drugs are sold online as bath salts. Designer drugs are often labeled as "not for human consumption" to circumvent drug abuse legislation. The absence of legal risks, the ease of obtaining these drugs, the moderate cost, and the availability via the Internet are the main features that attract users, but the number of intoxicated people presenting with emergencies is increasing. There is evidence that negative health and social consequences may affect recreational and chronic users. The addictive potential of designer drugs is not negligible.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24001292     DOI: 10.2174/13816128113199990622

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  13 in total

1.  The Psychoactive Surveillance Consortium and Analysis Network (PSCAN): the first year.

Authors:  Andrew A Monte; Andrew Hopkinson; Jessica Saben; Shelby K Shelton; Stephen Thornton; Aaron Schneir; Adam Pomerleau; Robert G Hendrickson; Ann M Arens; Jon B Cole; James Chenoweth; Spencer Martin; Axel Adams; Samuel D Banister; Roy R Gerona
Journal:  Addiction       Date:  2019-11-25       Impact factor: 6.526

2.  Rapid analysis of synthetic cannabinoids using a miniature mass spectrometer with ambient ionization capability.

Authors:  Qiang Ma; Hua Bai; Wentao Li; Chao Wang; R Graham Cooks; Zheng Ouyang
Journal:  Talanta       Date:  2015-04-24       Impact factor: 6.057

Review 3.  Intracranial self-stimulation to evaluate abuse potential of drugs.

Authors:  S Stevens Negus; Laurence L Miller
Journal:  Pharmacol Rev       Date:  2014-07       Impact factor: 25.468

4.  Characteristics and Treatment of Patients with Clinical Illness Due to Synthetic Cannabinoid Inhalation Reported by Medical Toxicologists: A ToxIC Database Study.

Authors:  Andrew A Monte; Diane P Calello; Roy R Gerona; Eike Hamad; Sharan L Campleman; Jeffery Brent; Paul Wax; Robert G Carlson
Journal:  J Med Toxicol       Date:  2017-04-10

Review 5.  Synthetic cathinones: a new public health problem.

Authors:  Laurent Karila; Bruno Megarbane; Olivier Cottencin; Michel Lejoyeux
Journal:  Curr Neuropharmacol       Date:  2015-01       Impact factor: 7.363

6.  Using cheminformatics to predict cross reactivity of "designer drugs" to their currently available immunoassays.

Authors:  Matthew D Krasowski; Sean Ekins
Journal:  J Cheminform       Date:  2014-05-10       Impact factor: 5.514

Review 7.  Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health.

Authors:  Aviv M Weinstein; Paola Rosca; Liana Fattore; Edythe D London
Journal:  Front Psychiatry       Date:  2017-08-23       Impact factor: 4.157

Review 8.  Cannabis, cannabinoids, and health.

Authors:  Genevieve Lafaye; Laurent Karila; Lisa Blecha; Amine Benyamina
Journal:  Dialogues Clin Neurosci       Date:  2017-09       Impact factor: 5.986

Review 9.  Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs.

Authors:  Zurina Hassan; Oliver G Bosch; Darshan Singh; Suresh Narayanan; B Vicknasingam Kasinather; Erich Seifritz; Johannes Kornhuber; Boris B Quednow; Christian P Müller
Journal:  Front Psychiatry       Date:  2017-08-18       Impact factor: 4.157

Review 10.  Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review From Public Health Prospective.

Authors:  Koby Cohen; Aviv M Weinstein
Journal:  Front Public Health       Date:  2018-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.